Form 4 for NEO NEOGENOMICS INC
Accepted 2022-05-20 00:00:00 ET · period of report 2022-05-18 · accession 0001077183-22-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-20 | 2022-05-18 | NEO | TETRAULT LYNN A. | Dir | M - OptEx | $7.27 | +3,334 | 39.1K | +9% | +$24.2K |
| D | 2022-05-20 | 2022-05-18 | NEO | TETRAULT LYNN A. | Dir | M - OptEx | $0.00 | -3,334 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-18 | M | A | 3,334 | $7.27 | 39,111 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-18 | M | D | 3,334 | $0.00 | 0 | D | $7.27 · — to 2022-05-25 | 3,334 Common Stock | (F1) On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. |